EMUCTV: How can we make TURBT better
November 6, 2026Read moreUROONCO BCa associate editor Dr. Roberto Contieri (IT) talks to Prof. Jonathan Aning (GB) on his lecture “How...
0
EMUCTV: RCC diagnostics in 2026
November 6, 2026Read moreUROONCO RCC associate editor Dr. Eduard Roussel (BE) talks to Dr. João Lobo (PT) on Renal Cell Carcinoma...
AI in GU cancers: From promise to clinical reality
November 6, 2026Read moreThe Plenary Session ‘AI in GU cancers: Clinical partner or complex distraction?’ featured two keynote lectures, as well as...
EMUCTV: Radioligand therapy in mHSPC
November 6, 2026Read moreUROONCO PCa assoicate editor Prof. Claudia Kesch (DE) interviews Assoc. Prof. Matteo Bauckneht (IT) on radioligand therapy in...
Factors to consider for individualised advanced PCa care
November 6, 2026Read morePlenary Session 1 “Individualised treatment in advanced prostate cancer” kickstarted with a clinical case presented by urologist Prof. Juan...
EMUCTV: PRIMARY 2 trial
November 5, 2026Read moreDr. Jennifer Le Guévelou (FR) speaks with Prof. Veeru Kasivisvanathan (GB) on the results of the PRIMARY 2...
EMUCTV: Histotripsy the new kid on the block final
November 5, 2026Read moreAssoc. Prof. Carlotta Palumbo (IT) discusses with Prof. Tze Min Wah (GB) about histotripsy being the new kid...
EMUCTV: FinnBladder 9 trial
November 5, 2026Read moreDr. Peter Boström (FI) discusses the FinnBladder 9 trial at EMUC26.
Biomarkers drive a new era in GU pathology
November 5, 2026Read moreExpert pathologists, radiologists, urologists, and medical oncologists presented and discussed current perspectives and future directions on urological pathology at...
